Advertisement

Topics

$ADRO $NVS STING agonist data at #SITC18 a bit better than abstract Now shows some single agent activity -- 5% ORR (2/40) http://investors.aduro.com/phoenix.zhtml?c=242043&p=irol-newsArticle&ID=2376492 …pic.twitter.com/Ibn7HRFtTX

07:39 EST 9 Nov 2018 | Andy Biotech

STING agonist data at a bit better than abstract Now shows some single agent activity -- 5% ORR (2/40) http://investors.aduro.com/phoenix.zhtml?c=242043&p=irol-newsArticle&ID=2376492 …

Original Article: $ADRO $NVS STING agonist data at #SITC18 a bit better than abstract Now shows some single agent activity -- 5% ORR (2/40) http://investors.aduro.com/phoenix.zhtml?c=242043&p=irol-newsArticle&ID=2376492 …pic.twitter.com/Ibn7HRFtTX

NEXT ARTICLE

More From BioPortfolio on "$ADRO $NVS STING agonist data at #SITC18 a bit better than abstract Now shows some single agent activity -- 5% ORR (2/40) http://investors.aduro.com/phoenix.zhtml?c=242043&p=irol-newsArticle&ID=2376492 …pic.twitter.com/Ibn7HRFtTX"

Advertisement
Quick Search
Advertisement
Advertisement